![Thomas A. Bologna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas A. Bologna
Président chez
CDx Diagnostics, Inc.
Profil
Is an experienced Chairman, President and Chief Executive Officer in leading public, venture and private equity backed diagnostic, pharmaceutical, device and clinical laboratory testing healthcare companies including turnarounds and start-ups, many of which he sold and/or took public.
Mr. Bologna was Chairman of the Board and Chief Executive Officer of Response Genetics, Inc., a clinical laboratory company, President and Chief Executive Officer of Orchid Cellmark, Inc., a leading DNA testing services company with operations in the United States and Europe, President and Chief Executive Officer of Quorex Pharmaceuticals, Chairman of the Board, President and Chief Executive Officer of Ostex International, Inc., a company that developed and commercialized products for the therapeutic management of osteoporosis and Chairman of the Board, President and Chief Executive Officer of Gen-Probe, Incorporated, a highly successful molecular diagnostics company.
Mr. Bologna also held senior level positions of highly profitable healthcare divisions and subsidiaries of Fortune 500 companies including President of the Becton Dickinson Diagnostic Instrument Systems Division.
He was also a founder and member of the Sponsoring Committee of the venture capital firm, Mission Ventures.
Mr. Bologna received his B.S.
from the New York University School of Engineering and Science and his M.B.A. from the New York University Graduate School of Business Administration.
Postes actifs de Thomas A. Bologna
| Sociétés | Poste | Début |
|---|---|---|
CDx Diagnostics, Inc.
 CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and delivers instruments for detection and prevention of cancers | Président | - |
Galen Management LLC
 Galen Management LLC Investment ManagersFinance Galen Management invests in companies located in the United States with revenues of USD 10 - 100 million and EBITDA of USD 0 - 9 million. The firm focuses on the health sector. It participates in growth capital requirements with an investment size of USD 10 - 100 million and also acquires minority or majority stakes. | Private Equity Investor | - |
CDx Medical Holdings, Inc.
 CDx Medical Holdings, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | - |
Anciens postes connus de Thomas A. Bologna
| Sociétés | Poste | Fin |
|---|---|---|
| QUOTIENT LIMITED | Directeur/Membre du Conseil | 29/10/2020 |
| STANDARD DIVERSIFIED INC | Président | 24/12/2013 |
| RESPONSE GENETICS, INC | Directeur Général | 09/10/2015 |
Cylex, Inc.
 Cylex, Inc. Medical SpecialtiesHealth Technology Manufactures and develops patented in vitro diagnostic products | Directeur/Membre du Conseil | 18/11/2013 |
Aperio Technologies, Inc.
 Aperio Technologies, Inc. Medical SpecialtiesHealth Technology Provides digital pathology systems and services | Directeur/Membre du Conseil | - |
Formation de Thomas A. Bologna
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Becton, Dickinson & Co.
 Becton, Dickinson & Co. Medical SpecialtiesHealth Technology Manufactures and sells medical supplies, devices, laboratory equipment & diagnostic products | Health Technology |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
Ostex International, Inc.
 Ostex International, Inc. Medical SpecialtiesHealth Technology Discovers and commercializes products associated with osteoporosis and other collagen-related diseases | Health Technology |
Standard Diversified, Inc.
 Standard Diversified, Inc. TobaccoConsumer Non-Durables Operates as holding company whose subsidiaries are engaged in tobacco, insurance and advertising business | Consumer Non-Durables |
Scriptgen Pharmaceuticals, Inc.
 Scriptgen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
Orchid Cellmark, Inc.
 Orchid Cellmark, Inc. Miscellaneous Commercial ServicesCommercial Services Provides DNA testing services | Commercial Services |
Aperio Technologies, Inc.
Aperio Technologies, Inc. Medical SpecialtiesHealth Technology Provides digital pathology systems and services | Health Technology |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets nucleic acid probe-based products for clinical diagnosis | Health Technology |
Cylex, Inc.
Cylex, Inc. Medical SpecialtiesHealth Technology Manufactures and develops patented in vitro diagnostic products | Health Technology |
Response Genetics, Inc.
 Response Genetics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical and diagnostic services | Health Technology |
Quorex Pharmaceuticals, Inc.
 Quorex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galen Management LLC
Galen Management LLC Investment ManagersFinance Galen Management invests in companies located in the United States with revenues of USD 10 - 100 million and EBITDA of USD 0 - 9 million. The firm focuses on the health sector. It participates in growth capital requirements with an investment size of USD 10 - 100 million and also acquires minority or majority stakes. | Finance |
Healthcare Venture Associates | |
Alba Bioscience, Inc.
 Alba Bioscience, Inc. Medical SpecialtiesHealth Technology Engages in the manufacturing of immunohematology products | Health Technology |
Quotient Ltd.
 Quotient Ltd. Medical SpecialtiesHealth Technology Develops and manufactures conventional reagent products | Health Technology |
CDx Diagnostics, Inc.
CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops and delivers instruments for detection and prevention of cancers | Health Technology |
CDx Medical Holdings, Inc.
CDx Medical Holdings, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
